What is the management of preeclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Preeclampsia

The definitive management of preeclampsia involves antihypertensive treatment for severe hypertension (SBP ≥160 mmHg and/or DBP ≥110 mmHg), magnesium sulfate for seizure prophylaxis in severe cases, and delivery timing based on disease severity and gestational age. 1, 2

Diagnostic Criteria

Preeclampsia is defined as gestational hypertension accompanied by ≥1 of the following new-onset conditions at or after 20 weeks' gestation:

  • Proteinuria (present in ~75% of cases but not required for diagnosis)
  • End-organ dysfunction:
    • Renal insufficiency
    • Liver involvement
    • Neurological complications
    • Hematological complications (thrombocytopenia)
    • Uteroplacental dysfunction (fetal growth restriction) 2

Initial Evaluation

  • Blood pressure monitoring
  • Laboratory assessment:
    • Complete blood count with platelets
    • Liver function tests
    • Renal function tests (creatinine, electrolytes, uric acid)
    • Urinalysis with protein/creatinine ratio
  • Fetal assessment:
    • Continuous fetal heart rate monitoring
    • Ultrasound for fetal growth
    • Amniotic fluid volume assessment
    • Doppler studies if growth restriction is suspected 2

Management Algorithm

1. Antihypertensive Treatment

  • Severe hypertension (SBP ≥160 mmHg and/or DBP ≥110 mmHg):
    • Immediate treatment is recommended to reduce maternal complications
    • First-line IV medications:
      • Labetalol
      • Hydralazine
      • Oral nifedipine
    • Target BP: Diastolic 85 mmHg, Systolic 110-140 mmHg 1, 2

2. Seizure Prophylaxis

  • Magnesium sulfate is recommended for:
    • Women with severe preeclampsia
    • Those with neurological signs/symptoms
    • Should be continued during labor and for at least 24 hours postpartum 2, 3

3. Corticosteroids

  • Administer for fetal lung maturation if delivery is anticipated between 24-34 weeks 2

4. Delivery Decision-Making

Immediate delivery is indicated for:

  • Gestational age ≥37 weeks with preeclampsia
  • Severe preeclampsia at ≥34 weeks
  • Any gestational age with:
    • Repeated episodes of severe hypertension despite treatment
    • Progressive thrombocytopenia
    • Progressive abnormal renal or liver function
    • Pulmonary edema
    • Abnormal neurological features
    • Non-reassuring fetal status
    • HELLP syndrome 2, 4

Expectant management may be considered for:

  • Select cases of severe preeclampsia between 24-34 weeks
  • Only in tertiary care centers with close maternal and fetal monitoring
  • Average prolongation of pregnancy: 7-15 days 5, 6

Contraindications to expectant management:

  • Imminent eclampsia
  • Multi-organ dysfunction
  • Severe fetal growth restriction
  • Suspected placental abruption
  • Non-reassuring fetal testing 4, 7

Postpartum Care

  • Continue blood pressure monitoring every 4-6 hours for at least 3 days
  • Taper antihypertensive medications slowly after days 3-6
  • Follow-up within 1 week if still on antihypertensives at discharge
  • Prescribe home blood pressure monitoring devices 2

Prevention Strategies

For high-risk women in future pregnancies:

  • Low-dose aspirin (81 mg/day) initiated between 12-16 weeks of gestation
  • Calcium supplements (1.0-1.5g elemental calcium daily), particularly for those with low calcium intake 2

Common Pitfalls and Caveats

  • Underestimating severity: Any new headache with hypertension should be considered preeclampsia until proven otherwise
  • Delayed treatment: Severe hypertension requires immediate treatment to prevent cerebrovascular complications
  • Inadequate monitoring: Patients with severe preeclampsia require intensive inpatient monitoring
  • Inappropriate expectant management: Should only be attempted in tertiary care centers with experienced teams
  • Premature discontinuation of magnesium sulfate: Should be continued for at least 24 hours postpartum 1, 2, 4

Remember that while delivery is always appropriate therapy for the mother, timing must balance maternal safety against fetal maturity when remote from term.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preeclampsia Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of preeclampsia.

Pregnancy hypertension, 2014

Research

Expectant management of severe preeclampsia remote from term.

Clinical obstetrics and gynecology, 1999

Research

Management of severe preeclampsia.

Acta clinica Belgica, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.